Back
Expeditors International of Washington Vs. Monopar Therapeutics Industry Stock Comparison
Sell
37
EXPD
Expeditors International of Washington
Last Price:
$111.03
Seasonality Move:
5.97%
Buy
77
MNPR
Monopar Therapeutics
Last Price:
$50.91
Seasonality Move:
-10.68%
Sell
37
Expeditors International of Washington (EXPD)
is a Sell
Is Expeditors International of Washington a Buy, Sell or Hold?
-
The current Expeditors International of Washington [EXPD] share price is $112.39. The Score for EXPD is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
EXPD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $51.33. The Score for MNPR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
MNPR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EXPD Stock Price Chart
What is Expeditors International of Washington's stock price today?
-
The Expeditors International of Washington share price today is $112.39Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EXPD is experiencing buying pressure, which is a positive indicator for future bullish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $51.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
EXPD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.48 | Sell |
Relative Strength Index (14 RSI): | 48.86 | Sell |
Chaikin Money Flow: | 374799 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (110.65 - 113.65) | Buy |
Bollinger Bands (100): | (112.84 - 123.26) | Sell |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.38 | Buy |
Relative Strength Index (14 RSI): | 70.65 | Buy |
Chaikin Money Flow: | 28022 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.36 - 46.32) | Buy |
Bollinger Bands (100): | (8.24 - 33.48) | Buy |
EXPD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 111.83 | Buy |
20-day SMA: | 112.44 | Sell |
50-day SMA: | 114.2 | Sell |
200-day SMA: | 119.48 | Sell |
8-day EMA: | 112.05 | Buy |
20-day EMA: | 112.39 | Sell |
50-day EMA: | 114.08 | Sell |
200-day EMA: | 118.12 | Sell |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.88 | Buy |
20-day SMA: | 39.84 | Buy |
50-day SMA: | 30.39 | Buy |
200-day SMA: | 12.08 | Buy |
8-day EMA: | 47.68 | Buy |
20-day EMA: | 41.31 | Buy |
50-day EMA: | 32.28 | Buy |
200-day EMA: | 16.59 | Buy |
Expeditors International of Washington Earnings Growth & EXPD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.44 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Expeditors International of Washington Technical Analysis
Jan 29 | Jan 30 | Jan 31 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | Feb | |||||||||
29 | 30 | 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Jan 29 | Jan 30 | Jan 31 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | Feb | |||||||||
29 | 30 | 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |